FN14 and GRP94 expression are prognostic/predictive biomarkers of brain metastasis outcome that open up new therapeutic strategies.

Martínez-Aranda, Antonio

FN14 and GRP94 expression are prognostic/predictive biomarkers of brain metastasis outcome that open up new therapeutic strategies. [electronic resource] - Oncotarget Dec 2015 - 44254-73 p. digital

Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

1949-2553

10.18632/oncotarget.5471 doi


Adult
Aged
Aged, 80 and over
Angiogenesis Inhibitors--therapeutic use
Animals
Area Under Curve
Astrocytes--drug effects
Biomarkers, Tumor--genetics
Brain Neoplasms--drug therapy
Breast Neoplasms--drug therapy
Carcinoma, Ductal, Breast--drug therapy
Cell Line, Tumor
Cytokine TWEAK
Female
Humans
Immunohistochemistry
Likelihood Functions
Membrane Glycoproteins--genetics
Mice, Nude
Middle Aged
Precision Medicine
Predictive Value of Tests
Prognosis
ROC Curve
Receptors, Tumor Necrosis Factor--genetics
Risk Assessment
Risk Factors
Spain
TWEAK Receptor
Thalidomide--therapeutic use
Tissue Array Analysis
Tumor Microenvironment
Tumor Necrosis Factors--metabolism
Xenograft Model Antitumor Assays
Young Adult